Skip to main content

Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / October 21, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET.

Interested parties may participate in the call by dialing:

(877) 407-6176 (US Toll-Free)

+1 (201) 689-8451 (International)

Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC

Following the live call, a replay will be available in the Investor Relations section of the Company's website at https://www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at https://www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.30
-2.43 (-1.01%)
AAPL  259.48
+1.20 (0.46%)
AMD  236.73
-15.45 (-6.13%)
BAC  53.20
+0.12 (0.23%)
GOOG  338.53
-0.13 (-0.04%)
META  716.50
-21.81 (-2.95%)
MSFT  430.29
-3.21 (-0.74%)
NVDA  191.13
-1.38 (-0.72%)
ORCL  164.58
-4.43 (-2.62%)
TSLA  430.41
+13.85 (3.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.